Timing of Withdrawal Bleeding After Progesterone
Withdrawal bleeding typically occurs within 2-7 days after completing a course of progesterone, with most women experiencing bleeding around 3-7 days post-treatment.
Expected Timeline
Based on FDA-approved progesterone clinical trials, 80% of women with adequate estrogen priming experienced withdrawal bleeding within 7 days of completing a 10-day course of progesterone 300 mg daily 1. The Endocrine Society guidelines note that progesterone challenge regimens include medroxyprogesterone acetate (5-10 mg/d for 5-10 days), norethindrone acetate (5 mg/d for 5-10 days), or micronized progesterone (200-300 mg/d for 10 days) 2.
Key Clinical Considerations
Absence of withdrawal bleeding is clinically significant and may indicate:
- Outflow tract obstruction (anatomical issue)
- Low endometrial estrogen exposure (inadequate estrogen priming)
The Endocrine Society specifically states that absence of withdrawal bleeding after progestin warrants further evaluation 2. If no bleeding occurs after the initial course, clinicians may start with a shorter 5-day course and repeat in a few weeks, with pelvic ultrasound follow-up to assess endometrial thickness and Müllerian tract integrity 2.
Dosing Variables
The timing can vary slightly based on:
- Dose administered: Higher doses (300-400 mg daily) showed 73.8-76.8% withdrawal bleeding rates in clinical trials 1
- Duration of treatment: Standard 10-day courses are most common
- Individual estrogen status: Adequate estrogen priming is essential for withdrawal bleeding to occur
Clinical Pitfall
Do not assume normal endometrial status based solely on bleeding timing. Research demonstrates that the timing of withdrawal bleeding onset does not correlate with endometrial histology or predict hyperplasia 3. The presence or absence of bleeding is diagnostically useful, but when bleeding occurs (day 11 vs day 13 vs day 15) provides no reassurance about endometrial pathology.
Practical Management
- Expect bleeding 2-7 days post-treatment in adequately estrogenized women
- If no bleeding occurs within 2-3 weeks, perform pelvic ultrasound to evaluate endometrial thickness
- Consider pregnancy testing if withdrawal bleeding does not occur within 3 weeks 4
- Repeat the challenge with a shorter course if initial attempt fails and adequate estrogen status is confirmed